2026 practice series · Editorial allocation: 9/2026. Added retrospectively on 13 November 2026; legal review date: 13 November 2026. The archive month does not represent an original publication on that date.
Veterinary medicines businesses should distinguish regulatory roles from contractual tasks. Authorisation holders, manufacturers, wholesalers and other partners do not automatically have identical duties. A clear allocation helps direct records, changes and reports to the right party in time.
Questions to resolve in practice
When adding distribution channels, negotiate more than prices and territory. Product information, market feedback, complaints and responses to possible safety issues belong in the agreement. The rules applicable to the product and activity remain decisive.
Legal assessment and practical approach
For veterinary medicines, start with product classification and the operator’s role. Authorisation, manufacturing, wholesale distribution, supply and advertising raise different requirements. Approval in one market does not settle every distribution question in another Member State.
Four practical examples
These are hypothetical scenarios illustrating issues to assess. They do not describe actual client matters or promise a particular outcome.
Practical example 1
A manufacturer develops a new dosage form for horses. Before investing in packaging and distribution, establish the authorisation route, documentation and permitted claims. Preserve development data so regulatory and contractual issues can be assessed separately.
Practical example 2
A trader offers veterinary medicines online across borders. Review product status, prescription requirements and national supply conditions. Operating a website abroad does not itself establish entitlement to supply the German market.
Practical example 3
Unexpected adverse effects are reported after delivery. The business needs a documented assessment of monitoring and reporting duties. Asking a contractual partner for information must not delay a required regulatory response.
Practical example 4
A practice considers using a medicine outside its authorised indication. The statutory conditions, species and treatment situation matter. A general agreement with the owner cannot replace this regulatory assessment.
Prepare the relevant evidence
Provide complete documents and a concise chronology. Distinguish your observations from statements by others and unresolved questions. Include attachments, evidence of service and deadlines with official notices and correspondence. Preserve original files, images and message histories unchanged; an organised working copy assists review.
Legal sources: Regulation (EU) 2019/6